These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 10404429)
1. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen. Chung MK; Yoon H; Min SS; Lee HG; Kim YJ; Lee TG; Lim JS; Kim CM; Park SN J Immunother; 1999 Jul; 22(4):279-87. PubMed ID: 10404429 [TBL] [Abstract][Full Text] [Related]
2. Peptide-specific CTL induction in HBV-seropositive PBMC by stimulation with peptides in vitro: novel epitopes identified from chronic carriers. Lee HG; Lim JS; Lee KY; Choi YK; Choe IS; Chung TW; Kim K Virus Res; 1997 Aug; 50(2):185-94. PubMed ID: 9282783 [TBL] [Abstract][Full Text] [Related]
3. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. Rehermann B; Fowler P; Sidney J; Person J; Redeker A; Brown M; Moss B; Sette A; Chisari FV J Exp Med; 1995 Mar; 181(3):1047-58. PubMed ID: 7532675 [TBL] [Abstract][Full Text] [Related]
4. Tumor eradication by hepatitis B virus X antigen-specific CD8+ T cells in xenografted nude mice. Chun E; Lee J; Cheong HS; Lee KY J Immunol; 2003 Feb; 170(3):1183-90. PubMed ID: 12538674 [TBL] [Abstract][Full Text] [Related]
5. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326 [TBL] [Abstract][Full Text] [Related]
6. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476 [TBL] [Abstract][Full Text] [Related]
8. [Detection of antigen-epitope-specific cytotoxic T lymphocytes in patients with hepatitis B virus infection by enzyme linked immunospot assay]. Zhang HP; Yan HP; Zhang YH; Feng X; Zhao Y; Liao HY; Liu YM; Chen Y; Tan YF; Liu Y Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Aug; 43(8):690-4. PubMed ID: 20021848 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734 [TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes. Tsai SL; Chen MH; Yeh CT; Chu CM; Lin AN; Chiou FH; Chang TH; Liaw YF J Clin Invest; 1996 Jan; 97(2):577-84. PubMed ID: 8567982 [TBL] [Abstract][Full Text] [Related]
11. Synthetic peptides of human papillomavirus type 18 E6 harboring HLA-A2.1 motif can induce peptide-specific cytotoxic T-cells from peripheral blood mononuclear cells of healthy donors. Yoon H; Chung MK; Min SS; Lee HG; Yoo WD; Chung KT; Jung NP; Park SN Virus Res; 1998 Mar; 54(1):23-9. PubMed ID: 9660068 [TBL] [Abstract][Full Text] [Related]
12. Identification and functional studies of HLA-A0201 restricted CTL epitopes in the X protein of hepatitis B virus. Guo YJ; Zhu Y; Sun SH Acta Virol; 2011; 55(2):107-15. PubMed ID: 21692558 [TBL] [Abstract][Full Text] [Related]
13. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*33:03 in peripheral blood mononuclear cells from patients and transgenic mice. Pan X; Ding H; Zhou X; Tien P Biochem Biophys Res Commun; 2014 Jun; 449(1):135-40. PubMed ID: 24813999 [TBL] [Abstract][Full Text] [Related]
14. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein. Liu Q; Zheng Y; Yu Y; Tan Q; Huang X Int Immunopharmacol; 2012 Jun; 13(2):141-7. PubMed ID: 22480777 [TBL] [Abstract][Full Text] [Related]
15. Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance. Vitiello A; Sette A; Yuan L; Farness P; Southwood S; Sidney J; Chesnut RW; Grey HM; Livingston B Eur J Immunol; 1997 Mar; 27(3):671-8. PubMed ID: 9079808 [TBL] [Abstract][Full Text] [Related]
16. In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus. Malmassari S; Lone YC; Zhang M; Transy C; Michel ML Microbes Infect; 2005 Apr; 7(4):626-34. PubMed ID: 15820153 [TBL] [Abstract][Full Text] [Related]
17. Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product. Oka Y; Elisseeva OA; Tsuboi A; Ogawa H; Tamaki H; Li H; Oji Y; Kim EH; Soma T; Asada M; Ueda K; Maruya E; Saji H; Kishimoto T; Udaka K; Sugiyama H Immunogenetics; 2000 Feb; 51(2):99-107. PubMed ID: 10663572 [TBL] [Abstract][Full Text] [Related]
18. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses. Oseroff C; Sette A; Wentworth P; Celis E; Maewal A; Dahlberg C; Fikes J; Kubo RT; Chesnut RW; Grey HM; Alexander J Vaccine; 1998 May; 16(8):823-33. PubMed ID: 9627940 [TBL] [Abstract][Full Text] [Related]
19. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response. Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633 [TBL] [Abstract][Full Text] [Related]
20. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Khanna R; Burrows SR; Nicholls J; Poulsen LM Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]